Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Hybridon licenses VEGF rights to Alnylam for ocular indications

Aug. 10, 2004

Ista submits sNDA for Vitrase as spreading agent

Aug. 10, 2004

Approvable letter for Lumigan-timolol combination

Aug. 5, 2004

Alcon patent covers new 5-HT2 agonists for glaucoma therapy

Aug. 5, 2004

ISTA launches Istalol for glaucoma

Aug. 2, 2004

FDA accepts for review Xibrom NDA

July 28, 2004

AzaSite enters two phase III studies for acute bacterial conjunctivitis

July 26, 2004

Completion of financing round at Acuity

July 21, 2004

Merck & Co. and Alnylam collaborate on RNAi therapeutics for ocular diseases

July 6, 2004

Alcon files second portion of Retaane rolling NDA

July 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...